Open Actively Recruiting

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

About

Brief Summary

A study to evaluate the safety and effectiveness of FemPulse System

Primary Purpose
The main objective of the intervention(s) being evaluated by the clinical trial. Learn more
Treatment
Study Type
The nature of the investigation or investigational use for which clinical study information is being submitted. Learn more
Interventional
Phase
N/A

Eligibility

Gender
Female
Healthy Volunteers
No
Minimum Age
21 Years
Maximum Age
N/A

Key Inclusion Criteria:

  • Females, defined as a person with a uterus and cervix, ≥21 years old, with a diagnosis of OAB and symptoms for more than 6 months, as confirmed by a physician. OAB is defined by urinary urgency, usually with urinary frequency and nocturia, with or without urgency urinary incontinence with symptoms
  • Willing and able to comply with study required procedures and visits (e.g., maintaining consistent medication use, fluid intake, diary completion).

Key Exclusion Criteria:

  • Systemic condition or disease that may interfere with study participation (e.g., current systemic infection, uncontrolled autoimmune disease, uncontrolled immunodeficiency disease, history of myocardial infarction, etc.) as determined by study investigator.
  • Not an appropriate study candidate as determined by investigator.
Study Stats
Protocol No.
25-0888
Category
Genitourinary Disorders
Principal Investigator
Lenny Ackerman
Contact
  • Katelyn Levitt
Location
  • UCLA Westwood
For Providers
NCT No.
NCT07195656
For detailed technical eligibility, visit ClinicalTrials.gov.